SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897069-05-000373
Filing Date
2005-02-11
Accepted
2005-02-11 16:21:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 cmw1205.htm SC 13G/A 158615
  Complete submission text file 0000897069-05-000373.txt   160841
Mailing Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 2125544555
MANHATTAN PHARMACEUTICALS INC (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51051 | Film No.: 05598939
SIC: 2834 Pharmaceutical Preparations

Mailing Address 181 W MADISON STE 3600 CHICAGO IL 60602
Business Address 181 W MADISON STE 3600 CHICAGO IL 60602 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A